Annovis Bio (ANVS)
(Delayed Data from NYSE)
$8.36 USD
+1.51 (22.04%)
Updated May 14, 2024 04:00 PM ET
After-Market: $8.50 +0.14 (1.67%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
ANVS 8.36 +1.51(22.04%)
Will ANVS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ANVS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ANVS
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
ANVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
Other News for ANVS
10 Health Care Stocks With Whale Alerts In Today's Session
ANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024
Stocks with more than 10% short interest - Finviz Screener
Largest borrow rate increases among liquid names
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results